Our equity analysts ask the right questions, dig deeper for answers and find details others miss. Our research division covers key Canadian healthcare companies to understand how they operate, recognize their relative strengths and weaknesses, and determine the impact of clinical and commercial developments and competitive events.
Our analysts make influential buy, sell and hold recommendations in healthcare and biotechnology, gather industry knowledge, and provide insightful market intelligence to help guide our investor clients.
Our Top Ideas; Healthcare Sector Review/Preview report, published annually, is essential reading for institutional investors to track historical sector performance and glean insight for the upcoming year, including milestones that could impact share performance.
Bloom Burton’s research products are disseminated simultaneously to all our customers who are authorized to receive them. Request to be added to Bloom Burton’s equity research distribution list. Email Brian Bloom at firstname.lastname@example.org.
The 13th edition of The Therapeutic Window, a report to be used by investors and industry executives as a directory of products (both marketed and in development) and upcoming milestones in the publicly-listed Canadian healthcare sector is out now.
For more information on our equity research services, please contact: